The Latin America, Middle East and Africa Anastomosis Devices Market would witness Market growth of 9.9% CAGR during the forecast period (2022-2028).
In developed nations, the development of technologically improved technologies and advantageous reimbursement circumstances in cardiac procedures such as open-heart valve replacement, Coronary Bypass Graft Surgery, and angioplasty are boosting the Market for anastomosis devices. For example, Medicare Part B covers procedures such as coronary artery bypass graft surgery, valve repair and replacement, coronary angioplasty, and various cardiac rehabilitation programs.
Anastomotic devices are ideal for addressing such requirements. They allow the coronary surgeon to improve their technique without sacrificing quality. They can reduce the risk of perioperative neurological damage by eliminating inter- and intra-surgeon variability in technical competency and ensuring the quick construction of reproducible, reliable, and compliant anastomoses, typically in difficult-to-access locations. A broad majority of anastomotic devices released into the Market in the last two decades are no longer in use.
According to the national Library of Medicines, cardiovascular disease is one of the leading causes of death in this region as well, however, the epidemiology of CVD in UAE nationals is unknown. The risk of significant CVD was linked to a low estimated glomerular filtration rate, high systolic blood pressure, and poorly controlled diabetes in high-risk UAE nationals who did not have a history of CVD. Smoking and high TC-to-HDL-C ratios, particularly in women, are controllable risk factors that should be proactively handled.
According to the World Health Organization, the global burden of chronic diseases is quickly increasing, with the Eastern Mediterranean Region experiencing the highest growth in cardiovascular disease. In addition, the UAE has one of the world's highest age-standardized mortality rates for cardiovascular disease, with males dying at 308.9 per 100,000 and females dying at 203.9 per 100,000.
The Brazil Market dominated the LAMEA Anastomosis Devices Market by Country 2021, and would continue to be a dominant Market till 2028; thereby, achieving a Market value of $86.6 million by 2028. The Argentina Market is poised to grow at a CAGR of 10.5% during (2022 - 2028). Additionally, The UAE Market would display a CAGR of 9.6% during (2022 - 2028).
Based on Product Type, the Market is segmented into Disposable and Reusable. Based on Application, the Market is segmented into Cardiovascular Surgery, Gastrointestinal Surgery and Others. Based on End User, the Market is segmented into Hospitals and Ambulatory Care Centers & Clinics. Based on countries, the Market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Anastomosis Devices Market is Predict to reach $4.8 Billion by 2028, at a CAGR of 5.5%
The Market research report covers the analysis of key stake holders of the Market . Key companies profiled in the report include Medtronic PLC, LivaNova PLC, Becton, Dickinson and Company, Johnson & Johnson, Peters Surgical, Smith & Nephew PLC, Boston Scientific Corporation, B. Braun Melsungen AG, ConMed Corporation, and Baxter International, Inc.
By Product Type
By Application
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
